rs62106244

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001130823.3(DNMT1):​c.892-84G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0394 in 1,427,718 control chromosomes in the GnomAD database, including 1,405 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 143 hom., cov: 31)
Exomes 𝑓: 0.040 ( 1262 hom. )

Consequence

DNMT1
NM_001130823.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0510

Publications

2 publications found
Variant links:
Genes affected
DNMT1 (HGNC:2976): (DNA methyltransferase 1) This gene encodes an enzyme that transfers methyl groups to cytosine nucleotides of genomic DNA. This protein is the major enzyme responsible for maintaining methylation patterns following DNA replication and shows a preference for hemi-methylated DNA. Methylation of DNA is an important component of mammalian epigenetic gene regulation. Aberrant methylation patterns are found in human tumors and associated with developmental abnormalities. Variation in this gene has been associated with cerebellar ataxia, deafness, and narcolepsy, and neuropathy, hereditary sensory, type IE. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNMT1 Gene-Disease associations (from GenCC):
  • autosomal dominant cerebellar ataxia, deafness and narcolepsy
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary sensory neuropathy-deafness-dementia syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 19-10163444-C-T is Benign according to our data. Variant chr19-10163444-C-T is described in ClinVar as Benign. ClinVar VariationId is 670503.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0341 (5197/152266) while in subpopulation NFE AF = 0.0478 (3253/68020). AF 95% confidence interval is 0.0465. There are 143 homozygotes in GnomAd4. There are 2674 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 5197 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001130823.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT1
NM_001130823.3
MANE Select
c.892-84G>A
intron
N/ANP_001124295.1
DNMT1
NM_001318730.2
c.844-84G>A
intron
N/ANP_001305659.1
DNMT1
NM_001379.4
c.844-84G>A
intron
N/ANP_001370.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT1
ENST00000359526.9
TSL:1 MANE Select
c.892-84G>A
intron
N/AENSP00000352516.3
DNMT1
ENST00000340748.8
TSL:1
c.844-84G>A
intron
N/AENSP00000345739.3
DNMT1
ENST00000591764.1
TSL:1
n.70-84G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0342
AC:
5197
AN:
152148
Hom.:
143
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00784
Gnomad AMI
AF:
0.0647
Gnomad AMR
AF:
0.0258
Gnomad ASJ
AF:
0.0170
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00725
Gnomad FIN
AF:
0.0948
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0478
Gnomad OTH
AF:
0.0292
GnomAD4 exome
AF:
0.0401
AC:
51125
AN:
1275452
Hom.:
1262
AF XY:
0.0394
AC XY:
25391
AN XY:
644056
show subpopulations
African (AFR)
AF:
0.00618
AC:
183
AN:
29630
American (AMR)
AF:
0.0198
AC:
874
AN:
44246
Ashkenazi Jewish (ASJ)
AF:
0.0205
AC:
511
AN:
24950
East Asian (EAS)
AF:
0.000104
AC:
4
AN:
38572
South Asian (SAS)
AF:
0.00656
AC:
540
AN:
82310
European-Finnish (FIN)
AF:
0.0850
AC:
4335
AN:
51026
Middle Eastern (MID)
AF:
0.0164
AC:
89
AN:
5430
European-Non Finnish (NFE)
AF:
0.0451
AC:
42653
AN:
945178
Other (OTH)
AF:
0.0358
AC:
1936
AN:
54110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
2368
4736
7105
9473
11841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1362
2724
4086
5448
6810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0341
AC:
5197
AN:
152266
Hom.:
143
Cov.:
31
AF XY:
0.0359
AC XY:
2674
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.00782
AC:
325
AN:
41568
American (AMR)
AF:
0.0258
AC:
394
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0170
AC:
59
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00767
AC:
37
AN:
4826
European-Finnish (FIN)
AF:
0.0948
AC:
1004
AN:
10588
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0478
AC:
3253
AN:
68020
Other (OTH)
AF:
0.0289
AC:
61
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
257
514
771
1028
1285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0442
Hom.:
254
Bravo
AF:
0.0274
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.70
DANN
Benign
0.64
PhyloP100
-0.051
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62106244; hg19: chr19-10274120; API